Any adverse events relating to Baxter products should be reported to Baxter’s Pharmacovigilance team using the following contact details:

Phone: 01635 206360

Email: [email protected]

Ensuring patient safety is extremely important to us and we take the safety of all our medicines and devices very seriously.

Adverse Events may also be reported to the MHRA; reporting forms and information can be found at

Important safety links

Information on the correct use of Baxter fibrin sealants with spray application: 

Information on the use of glucose monitors in patients using Extraneal: 

Any personal data sent to us will be protected, anonymised, entered into our safety database and reported to global government medicines agencies in line with the Baxter’s Privacy Policy and legal requirements.